Brief: Calix Says Partnering In Antimicrobial Resistance Research Program
09/05/2022 02:39
May 9 (Reuters) - Calix Ltd CXL.AX :
* PARTNERING IN ANTIMICROBIAL RESISTANCE RESEARCH PROGRAM
BACKED
BY A$34.5M IN AUSTRALIAN GOVERNMENT FUNDING
Source text for Eikon: ID:nASX3lVknr
Further company coverage: CXL.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Calix
See all newsBrief: Calix Signs Agreement With Perdaman For Hydrogen Supply To Zesty Green Iron Project
Brief: Calix Continues To Expect It Will Be Cash Flow Neutral In 2026
Australia's Calix rises on East Asia cement project contract
Australia's Calix logs best day in five months after deal with Ambuja Cement
Brief: Calix Declares JDA With Ambuja Cements For Commercial-Scale Project